How are Parkinson’s disease stages determined?

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts

How are Parkinson’s disease stages determined?

Parkinson’s disease (PD) is a progressive neurological disorder, and its stages are determined based on the severity and range of symptoms as well as the impact on daily activities. The most widely used staging system is the Hoehn and Yahr scale, which divides the progression of Parkinson’s disease into five stages. Here’s a detailed look at how these stages are determined:

Hoehn and Yahr Scale

The Hoehn and Yahr scale, first introduced in 1967, is a simple and commonly used method for describing how the symptoms of Parkinson’s disease progress. It ranges from Stage 1 (mild) to Stage 5 (advanced). Each stage is characterized by specific symptoms and their impact on a person’s daily life.

Stage 1: Mild Symptoms

Symptoms:
- Symptoms are mild and typically occur on only one side of the body (unilateral involvement).
- The most common early symptom is a tremor in one hand.
Impact on Daily Life:
- Symptoms are usually not severe enough to interfere with daily activities.
- There may be slight changes in posture, walking, and facial expressions.
Diagnosis:
- Often diagnosed based on the presence of unilateral symptoms and a response to dopaminergic medication.

Stage 2: Bilateral Symptoms

Symptoms:
- Symptoms begin to affect both sides of the body (bilateral involvement).
- There may be increased tremor, rigidity, and bradykinesia (slowness of movement).
Impact on Daily Life:
- Daily activities may become more difficult but can still be completed.
- Posture and gait changes become more noticeable.
Diagnosis:
- Symptoms are more apparent and a neurological examination confirms bilateral involvement.

Stage 3: Moderate Symptoms

Symptoms:
- Loss of balance and slowness of movement become more pronounced.
- Postural instability becomes evident, increasing the risk of falls.
Impact on Daily Life:
- Significant impact on daily activities; patients may need assistance with some tasks.
- Still able to live independently, but with considerable effort and potential need for help.
Diagnosis:
- A neurological exam shows clear postural instability and bilateral symptoms.

Stage 4: Severe Symptoms

Symptoms:
- Severe disability, but patients can still walk or stand unassisted.
- Tremor, rigidity, and bradykinesia are severe.
Impact on Daily Life:
- Daily activities are markedly restricted.
- The patient requires substantial help and cannot live alone safely.
Diagnosis:
- Severe symptoms are evident on examination, and significant functional limitations are observed.

Stage 5: Advanced Symptoms

Symptoms:
- Symptoms are very severe and incapacitating.
- Patients may be unable to stand or walk and are often confined to a wheelchair or bed.
Impact on Daily Life:
- 24-hour care is required for all activities of daily living.
- Patients are dependent on others for almost all aspects of care.
Diagnosis:
- The patient’s inability to perform basic movements independently confirms the stage.

Unified Parkinson’s Disease Rating Scale (UPDRS)

While the Hoehn and Yahr scale is useful for a general classification of disease progression, the Unified Parkinson’s Disease Rating Scale (UPDRS) provides a more comprehensive assessment of Parkinson’s disease severity. The UPDRS includes the following sections:

Mentation, Behavior, and Mood: Assesses cognitive impairment, depression, and other psychiatric symptoms.
Activities of Daily Living (ADL): Evaluates the impact of Parkinson’s on daily activities such as eating, dressing, and hygiene.
Motor Examination: Measures motor symptoms including tremor, rigidity, bradykinesia, and postural instability.
Complications of Therapy: Addresses issues related to the treatment, such as motor fluctuations and dyskinesias.

Clinical Assessment and Diagnosis

To determine the stage of Parkinson’s disease, a neurologist will perform a thorough clinical assessment, which includes:

Medical History:
- Detailed discussion of symptoms, their onset, and progression.
- Review of medical history, family history, and medications.
Neurological Examination:
- Evaluation of motor symptoms: tremor, rigidity, bradykinesia, and postural instability.
- Assessment of gait, balance, and coordination.
Functional Assessment:
- Observation of the patient’s ability to perform daily activities.
- Use of rating scales like the Hoehn and Yahr scale and the UPDRS.
Response to Medication:
- Observation of symptom improvement in response to dopaminergic medications can provide insights into disease severity and progression.

Conclusion

The staging of Parkinson’s disease using the Hoehn and Yahr scale provides a clear framework for understanding the progression of the disease, from mild to advanced stages. The UPDRS offers a more detailed and nuanced assessment of the impact of Parkinson’s on various aspects of a patient’s life. By combining these tools with a thorough clinical assessment, neurologists can accurately determine the stage of Parkinson’s disease and tailor treatment plans to address the specific needs and challenges faced by patients at each stage.

Jodi Knapp